This report series examines quarterly trends in life sciences venture investment. Key findings for Q2 2023 include:
• Life sciences VC deal value in Q2 2023 totaled $6.7 billion across 384 deals, representing a slight increase in value and a moderate decrease in deal count from the previous quarter. YTD deal value of $13.1 billion represents 34.3% of 2022’s annual total.
Please see full publication below for more information.
